Huarong Kingsung Medical Technology Wins First Prize at National Competition with China's First PGA Neural Repair Tube

Recently, Youlepu — Absorbable Neural Repair Tube, independently developed by Huarong Kingsung Medical Technology Co.,Ltd., a company based in Tianjin Economic-Technological Development Area (TEDA), won first prize in the Growth Group Final of the 9th China Medical Devices Design & Entrepreneurship Competition(2026). The competition has been held for eight consecutive editions and has attracted more than 6,000 participating projects to date. The award represents authoritative industry recognition of the product's innovation and its value for commercialization.

Peripheral nerves are fine and slender, and end-to-end coaptation of severed nerves is technically demanding. A single misconnection can compromise functional recovery. Developed with the support of National Basic Research Program (the "973" Program) and guided by the consensus of academicians and experts, Huarong Kingsung 's product is built around a polyglycolic acid (PGA) textile mesh tube. Its corrugated wall structure combines mechanical support with flexibility, preventing collapse at the anastomosis site and guiding the directional growth of nerve fibers. The company has overcome key process challenges, such as spinning ultrafine multifilament yarns, seamless braiding of small-diameter straight tubes, and continuous helical setting , achieving selective nutrient permeability alongside stable structural support. Several of these technologies have reached internationally advanced levels.

Huarong Kingsung  serves as the R&D and manufacturing headquarters of Kingsung Medical Group. It landed in TEDA West in 2014 and is recognized as a National High-Tech Enterprise and a Tianjin "Specialized, Refined, Differential and Innovative" SME, with more than 220 patents filed. TEDA is now home to a cluster of high-quality medical device companies, including Huarong Kingsung , Reach Surgical, and Sinomed and has formed four competitive subsectors: implantable and interventional devices, surgical instruments, in vitro diagnostic reagents, and medical device services.